Morningside Venture Investments Limited 13D and 13G filings for Kezar Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-16 6:33 pm Sale |
2024-12-03 | 13D | Kezar Life Sciences, Inc. KZR |
Morningside Venture Investments Limited | 616,502 8.450% |
-8,953 (-1.43%) |
Filing |
| 2023-08-17 5:14 pm Unchanged |
2023-08-15 | 13D | Kezar Life Sciences, Inc. KZR |
Morningside Venture Investments Limited | 625,455 8.600% |
0 (Unchanged) |
Filing |
| 2021-02-16 4:15 pm Unchanged |
2020-12-31 | 13D | Kezar Life Sciences, Inc. KZR |
Morningside Venture Investments Limited | 625,455 13.500% |
0 (Unchanged) |
Filing |
| 2020-06-16 4:10 pm Purchase |
2020-06-11 | 13D | Kezar Life Sciences, Inc. KZR |
Morningside Venture Investments Limited | 625,455 13.700% |
14,549 (+2.38%) |
Filing |